Dukes Russell K MD is categorized under Internal Medicine Doctors in Bloomington, IN and active since 2010.
Dukes Russell K MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Russell Dukes at the company’s single location by writing to 550 South Landmark Avenue, Bloomington, Indiana IN 47403 or by phoning (812) 331-3400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Dukes Russell K MD |
| Contact Person: | Russell Dukes |
| Address: | 550 South Landmark Avenue, Bloomington, Indiana 47403 |
| Phone Number: | (812) 331-3400 |
| Website Address: | ima-md.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Dukes Russell K MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Russell Dukes for inquiries that concern Dukes Russell K MD by calling the company number (812) 331-3400, as your correspondence is most welcome. Additionally, the physical location of the single location of Dukes Russell K MD can be found at the coordinates 39.16139,-86.55444 as well as the street address 550 South Landmark Avenue in Bloomington, Indiana 47403.
For its online presence, you may visit Dukes Russell K MD’s website at ima-md.com and engage with its social media outlets through on Twitter and on Facebook.